Peter. V. Danenberg

Peter. V. Danenberg's AcademicInfluence.com Rankings

Peter. V. Danenberg

Biology

#11821

World Rank

#15246

Historical Rank

Molecular Biology

#1862

World Rank

#1891

Historical Rank

biology Degrees

Download Badge

Biology

Peter. V. Danenberg's Degrees

PhD Molecular Biology Stanford University

Why Is Peter. V. Danenberg Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Peter. V. Danenberg's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

MethyLight: a high-throughput assay to measure DNA methylation. (2000) (1404)
Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. (2000) (850)
Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. (1995) (702)
Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. (2002) (671)
ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy. (2001) (659)
ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. (1998) (523)
Thymidylate synthetase - a target enzyme in cancer chemotherapy. (1977) (505)
Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. (1997) (503)
Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival. (2001) (471)
An In vivo Platform for Translational Drug Development in Pancreatic Cancer (2006) (427)
CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. (1999) (422)
Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. (2000) (380)
Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. (2000) (376)
Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. (1996) (362)
Fluorinated pyrimidines and their nucleosides. (1983) (356)
NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. (1992) (348)
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine. (2006) (331)
Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. (2002) (314)
Standing the test of time: targeting thymidylate biosynthesis in cancer therapy (2014) (293)
High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil. (1998) (254)
Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression. (2001) (240)
Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin. (1999) (231)
p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survival. (1998) (226)
Thymidylate synthetase: mechanism of inhibition by 5-fluoro-2'-deoxyuridylate. (1972) (193)
Telomerase reverse transcriptase expression is increased early in the Barrett’s metaplasia, dysplasia, adenocarcinoma sequence (2000) (178)
Effect of 5, 10-methylenetetrahydrofolate on the dissociation of 5-fluoro-2'-deoxyuridylate from thymidylate synthetase: evidence for an ordered mechanism. (1978) (170)
Structures of reversible and irreversible complexes of thymidylate synthetase and fluorinated pyrimidine nucleotides. (1974) (164)
p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site. (1998) (157)
High Gene Expression of TS1, GSTP1, and ERCC1 Are Risk Factors for Survival in Patients Treated with Trimodality Therapy for Esophageal Cancer (2005) (146)
Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival (2001) (145)
MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy. (2010) (144)
Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil. (1984) (141)
High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF. (2008) (140)
Biochemical factors affecting the tightness of 5-fluorodeoxyuridylate binding to human thymidylate synthetase. (1981) (134)
Prognostic Significance of Cyclooxygenase 2 mRNA Expression in Non-Small Cell Lung Cancer (2002) (131)
Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes. (1999) (122)
Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a phase I/II trial. (2003) (121)
High Specificity of Quantitative Excision Repair Cross-Complementing 1 Messenger RNA Expression for Prediction of Minor Histopathological Response to Neoadjuvant Radiochemotherapy in Esophageal Cancer (2004) (119)
Both β‐actin and GAPDH are useful reference genes for normalization of quantitative RT‐PCR in human FFPE tissue samples of prostate cancer (2008) (116)
Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma. (1998) (116)
Loss of Heterozygosity at the Thymidylate Synthase (TS) Locus on Chromosome 18 Affects Tumor Response and Survival in Individuals Heterozygous for a 28-bp Polymorphism in the TS Gene (2004) (113)
Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome. (2003) (107)
Epidermal Growth Factor Receptor Messenger RNA Expression, Gene Dosage, and Gefitinib Sensitivity in Non–Small Cell Lung Cancer (2006) (103)
Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy. (1997) (102)
Vascular Endothelial Growth Factor Messenger RNA Expression Level Is Preserved in Liver Metastases Compared with Corresponding Primary Colorectal Cancer (2006) (97)
Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase. (2000) (94)
Human equilibrative nucleoside transporter 1 is associated with the chemosensitivity of gemcitabine in human pancreatic adenocarcinoma and biliary tract carcinoma cells. (2007) (89)
HER‐2 receptor expression, localization, and activation in colorectal cancer cell lines and human tumors (2004) (87)
The incorporation of 5-fluoro-2'-deoxyuridine into DNA of mammalian tumor cells. (1981) (83)
Low ERCC 1 Expression Correlates with Prolonged Survival after Cisplatin plus Gemcitabine Chemotherapy in Non-Small Cell Lung Cancer 1 (2002) (81)
Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma. (2005) (79)
Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus. (2003) (77)
Kinetics and mechanism of interaction of 10-propargyl-5,8-dideazafolate with thymidylate synthase. (1986) (76)
Thymidylate synthase expression in advanced colorectal cancer predicts for response to raltitrexed. (2003) (74)
Osteopontin But Not Osteonectin Messenger RNA Expression Is a Prognostic Marker in Curatively Resected Non-Small Cell Lung Cancer (2004) (73)
Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen. (2001) (71)
DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value. (2006) (67)
Thymidylate synthase inhibitors. (1999) (66)
Concurrent paclitaxel and radiation therapy for breast cancer. (1999) (66)
Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosis. (2004) (66)
Therapeutic response of leukemic mice treated with fluorinated pyrimidines and inhibitors of deoxyuridylate synthesis. (1982) (65)
A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus (2004) (65)
Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus. (2006) (64)
Original p53 status predicts for pathological response in locally advanced breast cancer patients treated preoperatively with continuous infusion 5-fluorouracil and radiation therapy. (1997) (64)
Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett's esophagus with antireflux surgery. (2007) (63)
Fluorinated pyrimidines as tight-binding inhibitors of thymidylate synthetase. (1981) (63)
Human leukemic cells resistant to 5-fluoro-2'-deoxyuridine contain a thymidylate synthetase with lower affinity for nucleotides. (1983) (63)
Serum lactate dehydrogenase levels and glycolysis significantly correlate with tumor VEGFA and VEGFR expression in metastatic CRC patients. (2007) (63)
Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer. (2005) (63)
Functional Polymorphism of the Thymidylate Synthase Gene in Colorectal Cancer Accompanied by Frequent Loss of Heterozygosity (2002) (61)
Alterations of p16 and p14ARF genes and their 9p21 locus in oral squamous cell carcinoma. (2009) (60)
Detection of point mutations in human DNA by analysis of RNA conformation polymorphism(s). (1992) (59)
Association between Cyclooxygenase expression and colorectal adenoma characteristics. (2003) (58)
Phenylalanyl transfer ribonucleic acid synthetase from Escherichia coli. Reaction parameters and order of substrate addition. (1971) (57)
Biomarkers for Cetuximab-Based Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer (2011) (56)
Tumor suppressor gene P53 mutations in human prostate cancer (1995) (55)
Transfection of wild-type but not mutant p53 induces early monocytic differentiation in HL60 cells and increases their sensitivity to stress. (1995) (48)
Evidence for a sequential interaction of the subunits of thymidylate synthetase. (1979) (48)
A Three-Gene Signature for Outcome in Soft Tissue Sarcoma (2009) (47)
Expression of DT-diaphorase and cytochrome P450 reductase correlates with mitomycin C activity in human bladder tumors. (2001) (46)
Glutathione S-transferase-Pi expression is downregulated in patients with Barrett’s esophagus and esophageal adenocarcinoma (2002) (46)
Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis. (2008) (45)
Thymidylate synthase, dihydropyrimidine dehydrogenase, ERCC1, and thymidine phosphorylase gene expression in primary and metastatic gastrointestinal adenocarcinoma tissue in patients treated on a phase I trial of oxaliplatin and capecitabine (2008) (43)
Gene profiling and pathway analysis of neuroendocrine transdifferentiated prostate cancer cells (2009) (43)
High Expression of Heparanase is Significantly Associated with Dedifferentiation and Lymph Node Metastasis in Patients with Pancreatic Ductal Adenocarcinomas and Correlated to PDGFA and Via HIF1a to HB-EGF and bFGF (2008) (42)
The role of retinoid X receptor messenger RNA expression in curatively resected non-small cell lung cancer. (2002) (42)
The Molecular Signature of Normal Squamous Esophageal Epithelium Identifies the Presence of a Field Effect and Can Discriminate between Patients with Barrett's Esophagus and Patients with Barrett's-Associated Adenocarcinoma (2005) (42)
Incorporation of 5-fluorouracil into U2 and U6 snRNA inhibits mRNA precursor splicing. (1994) (41)
TS and ERCC-1 mRNA expressions and clinical outcome in patients with metastatic colon cancer in CONFIRM-1 and -2 clinical trials (2011) (41)
Thymidylate synthetase purified to homogeneity from human leukemic cells. (1979) (41)
Quantitative, tissue-specific analysis of cyclooxygenase gene expression in the pathogenesis of Barrett’s adenocarcinoma (2004) (41)
Genistein‐induced neuroendocrine differentiation of prostate cancer cells (2006) (41)
Multiparametric liquid biopsy analysis in metastatic prostate cancer. (2019) (41)
Phenylalanyl transfer ribonucleic acid synthetase from Escherichia coli. Analysis of the phenylalanine binding site. (1971) (41)
DPD is a molecular determinant of capecitabine efficacy in colorectal cancer. (2007) (40)
Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types. (2016) (40)
Analyses of p53 gene mutations in primary human bladder cancer. (1993) (40)
Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma. (2001) (39)
5‐fluorouracil‐related gene expression levels in primary colorectal cancer and corresponding liver metastasis (2006) (38)
Effect of 5-fluoro- and 5-bromouracil substitution on the translation of human thymidylate synthase mRNA. (1995) (37)
Low HER2/neu gene expression is associated with pathological response to concurrent paclitaxel and radiation therapy in locally advanced breast cancer. (2002) (37)
Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in breast cancer predicts 5-FU sensitivity by a histocultural drug sensitivity test. (2004) (37)
Pharmacogenomics of thymidylate synthase in cancer treatment. (2004) (37)
Intratumoral COX-2 Gene Expression Is a Predictive Factor for Colorectal Cancer Response to Fluoropyrimidine-Based Chemotherapy (2005) (36)
Increased acid exposure in patients with gastroesophageal reflux disease influences cyclooxygenase-2 gene expression in the squamous epithelium of the lower esophagus. (2004) (35)
Antireflux Surgery Normalizes Cyclooxygenase-2 Expression in Squamous Epithelium of the Distal Esophagus (2006) (35)
Restoration of wild-type p53 activity in p53-null HL-60 cells confers multidrug sensitivity. (1998) (33)
Assay and time course of 5-fluorouracil incorporation into RNA of L1210/0 ascites cells in vivo. (1985) (32)
Epidermal growth factor receptor and epidermal growth factor receptor variant III gene expression in metastatic colorectal cancer. (2006) (31)
Plasma DNA is more reliable than carcinoembryonic antigen for diagnosis of recurrent esophageal cancer. (2008) (31)
Plasma DNA as a molecular marker for completeness of resection and recurrent disease in patients with esophageal cancer. (2007) (31)
Survivin, a potential biomarker in the development of Barrett's adenocarcinoma. (2005) (31)
Retinoic acid receptor-α messenger RNA expression is increased and retinoic acid receptor-γ expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence (2001) (30)
Increased p21/WAF-1 and p53 protein levels following sequential three drug combination regimen of fludarabine, cytarabine and docetaxel induces apoptosis in human leukemia cells. (1998) (30)
Upregulation of ornithine decarboxylase mrna expression in barrett’s esophagus and barrett’s-associated adenocarcinoma (2001) (30)
Sex differences in the predictive power of the molecular prognostic factor HER2/neu in patients with non-small-cell lung cancer. (2006) (30)
Molecular determinants in targeted therapy for esophageal adenocarcinoma. (2006) (29)
Differential SPARC mRNA expression in Barrett's oesophagus (2003) (29)
Conformational polymorphisms of cRNA of T-cell-receptor genes as a clone-specific molecular marker for cutaneous lymphoma. (1993) (28)
Increasing cyclooxygenase‐2 (cox‐2) gene expression in the progression of Barrett's esophagus to adenocarcinoma correlates with that of Bcl‐2 (2006) (27)
Thymidylate synthetase and 2'-deoxyuridylate form a tight complex in the presence of pteroyltriglutamate. (1979) (27)
High frequency of simultaneous loss of p16 and p16β gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach (1997) (27)
Folates as adjuvants to anticancer agents: Chemical rationale and mechanism of action. (2016) (27)
Molecular profiling including epidermal growth factor receptor and p21 expression in high-risk breast cancer patients as indicators of outcome. (2008) (27)
Quantitative analysis of folylpolyglutamate synthetase gene expression in tumor tissues by the polymerase chain reaction: marked variation of expression among leukemia patients. (1994) (26)
Deoxyuridylate effects on thymidylate synthase-5-fluorodeoxyuridylate-folate ternary complex formation. (1989) (25)
Update of prognostic and predictive biomarkers in oropharyngeal squamous cell carcinoma: a review (2010) (25)
Hydrodynamic behavior of human and bacterial thymidylate synthetases and thymidylate synthetase--5-fluoro-2'-deoxyuridylate--5,10-methylenetetrahydrofolate complexes. Evidence for large conformational changes during catalysis. (1980) (25)
The effect of Raney nickel on the covalent thymidylate synthetase-5-fluoro-2'-deoxyuridylate-5,10-methylenetetrahydrofolate complex. (1976) (25)
p53 gene mutation in primary human renal cell carcinoma. (1992) (25)
Expression of thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, and orotate phosphoribosyl transferase in prostate cancer (2005) (24)
EGFR, FLT1 and Heparanase as Markers Identifying Patients at Risk of Short Survival in Cholangiocarcinoma (2013) (24)
Prediction of chemosensitivity of colorectal cancer to 5-fluorouracil by gene expression profiling with cDNA microarrays. (2005) (23)
Quantitative measurement of relative gene expression in human tumors. (1993) (23)
Inhibition of pre-mRNA splicing by cisplatin and platinum analogs. (2003) (23)
High intratumoral dihydropyrimidine dehydrogenase mRNA levels in pancreatic cancer associated with a high rate of response to S-1 (2008) (22)
Regulation of MLH1 mRNA and protein expression by promoter methylation in primary colorectal cancer: a descriptive and prognostic cancer marker study (2013) (22)
Desensitization and sensitization of cells to fluoropyrimidines with different antisenses directed against thymidylate synthase messenger RNA. (1998) (22)
Phenylalanyl transfer ribonucleic acid synthetase from Escherichia coli. Analysis of the adenosine triphosphate binding site. (1971) (21)
Separate identities of ligandin and the h-protein, a major protein to which carcinogenic hydrocarbons are covalently bound. (1976) (21)
Validation of a rodent model of Barrett’s esophagus using quantitative gene expression profiling (2009) (21)
Interaction of 5-ethynyl-2'-deoxyuridylate with thymidylate synthetase. (1981) (21)
Retinoic acid receptor-alpha messenger RNA expression is increased and retinoic acid receptor-gamma expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence. (2001) (21)
A novel RT-PCR approach to detecting EML4-ALK fusion genes in archival NSCLC tissue. (2010) (20)
Expression and clinical significance of methylenetetrahydrofolate reductase in patients with colorectal cancer. (2006) (20)
Purification of thymidylate synthetase from L. casei by affinity chromatography. (1972) (20)
Adenocarcinoma developing in de novo Barrett's mucosa in the remnant esophagus after esophagectomy: clinical and molecular assessment. (2008) (19)
Gene amplification and multidrug resistance induced by the phosphatase-inhibitory tumor promoter, okadaic acid. (1995) (19)
Synthesis and interaction with uridine phosphorylase of 5'-deoxy-4',5-difluorouridine, a new prodrug of 5-fluorouracil. (1988) (19)
Efficacy of laser capture microdissection plus RT-PCR technique in analyzing gene expression levels in human gastric cancer and colon cancer (2008) (18)
Thymidylate synthase polymorphisms and mRNA expression are independent chemotherapy predictive markers in esophageal adenocarcinoma patients. (2008) (18)
Synthesis and biological activity of 5'-substituted 5-fluoropyrimidine nucleosides. (1982) (18)
Activity of thymidylate synthetase and its inhibition by 5-fluorouracil in highly enzyme-overproducing cells resistant to 10-propargyl-5,8-dideazafolate. (1989) (18)
Role of Retinoid X receptor mRNA expression in Barrett’s esophagus (2004) (17)
Histology- and gender-related associations of ERCC1, RRM1, and TS biomarkers in 1,802 patients with NSCLC: Implications for therapy. (2010) (17)
Molecular factors of 5-fluorouracil metabolism in colorectal cancer: analysis of primary tumor and lymph node metastasis. (2006) (17)
Predictors of response and survival for neoadjuvant treated patients with esophageal adenocarcinoma. (2008) (17)
Intratumoral expression profiling of genes involved in angiogenesis in colorectal cancer patients treated with chemotherapy plus the VEGFR inhibitor PTK787/ZK 222584 (vatalanib) (2012) (16)
Growth inhibition of cells in cultures and of vaccinia virus infected HeLa cells by derivatives of trifluorothymidine. (1976) (16)
Response prediction in metastasised colorectal cancer using intratumoural thymidylate synthase: results of a randomised multicentre trial. (2012) (16)
Markedly Decreased Binding of Vincristine to Tubulin in Vinca Alkaloid-Resistant Chinese Hamster Cells Is Associated with Selective Overexpression of α and β Tubulin Isoforms (2000) (16)
Induction of mutations by 5-fluorodeoxyuridine: a mechanism of self-potentiated drug resistance? (1983) (15)
Low thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase mRNA expression correlate with prolonged survival in resected non-small-cell lung cancer. (2010) (15)
Epidermal growth factor receptor (EGFR) mRNA levels and protein expression levels in primary colorectal cancer and corresponding liver metastases (2010) (15)
Glutathione S-transferase PI (GST-PI) mRNA expression and DNA methylation is involved in the pathogenesis and prognosis of NSCLC. (2012) (15)
Effect of 5-fluorouracil substitution on the self-splicing activity of Tetrahymena ribosomal RNA. (1990) (15)
Differential S100 beta expression in choroidal and skin melanomas: quantitation by the polymerase chain reaction. (1993) (15)
Prognostic Significance and Clinicopathological Associations of COX-2 SNP in Patients with Nonsmall Cell Lung Cancer (2009) (14)
The interaction of liver alcohol dehydrogenase with phenyl adenine dinucleotide, a novel analog of pyridine nucleotide coenzymes. (1978) (14)
Advances in Brief Epidermal Growth Factor Receptor and HER 2-neu mRNA Expression in Non-Small Cell Lung Cancer Is Correlated with Survival (2001) (14)
Predictive value of MSH2 gene expression in colorectal cancer treated with capecitabine. (2007) (14)
Modulation of RTX cytotoxicity by thymidine and dipyridamole in vitro: implications for chemotherapy (2000) (14)
Gene expression levels of epidermal growth factor receptor, survivin, and vascular endothelial growth factor as molecular markers of lymph node involvement in patients with locally advanced rectal cancer. (2006) (14)
Messenger RNA expression of TS and ERCC1 in colorectal cancer and matched liver metastasis. (2008) (13)
Thymidylate synthetase — substrate complex formation (1982) (13)
Rapid Activation of MDR 1 Gene Expression in Human Metastatic Sarcoma after in Vivo Exposure to Doxorubicin 1 (1999) (13)
Spectroscopic studies of ternary complexes of thymidylate synthetase, deoxyribonucleotides, and folate analogs. (1984) (12)
Synthesis and biological activity of 5-fluoro-2',3'-dideoxy-3'-fluorouridine and its 5'-phosphate. (1984) (12)
Efficiency of fluorodeoxyglucose positron emission tomography/computed tomography to predict prognosis in breast cancer patients received neoadjuvant chemotherapy (2015) (12)
Synthesis and biological activity of 5-fluoro-2'-deoxyuridine 5'-phosphorodiamidates. (1980) (11)
Gender differences in the predictive power of prognostic factors in NSCLC (2004) (11)
Tight-binding complexes of thymidylate synthetase, folate analogs and deoxyribonucleotides. (1982) (11)
Cyclooxygenase-2 in Barrett's Esophagus, Barrett's Adenocarcinomas, and Esophageal SCC: Ready for Clinical Trials (1999) (11)
Concentration and time dependence of the toxicity of fluorinated pyrimidines to HT 29 colorectal carcinoma cells (2004) (11)
Reversal of cytosine arabinoside (ara-C) resistance by the synergistic combination of 6-thioguanine plus ara-C plus PEG-asparaginase (TGAP) in human leukemia lines lacking or expressing p53 protein (2001) (11)
Expression of metastases-associated genes in cervical cancers resected in the proliferative and secretory phases of the menstrual cycle. (2000) (11)
Molecular predictors of lymph node metastasis in colon cancer: Increased risk with decreased thymidylate synthase expression (2005) (10)
Messenger RNA expression of COX-2 and angiogenic factors in primary colorectal cancer and corresponding liver metastasis. (2009) (10)
Inactivation of Tetrahymena rRNA self-splicing by cis-platin proceeds through dissociable complexes. (1991) (10)
KRAS mutations (MTs) in non-small cell lung cancer (NSCLC) versus colorectal cancer (CRC): Implications for cetuximab therapy. (2010) (9)
Synthesis and biological studies of 3-(beta-D-ribofuranosyl)-2,3,-dihydro-6H-1,3-oxazine-2,6-dione, a new pyrimidine nucleoside analog related to uridine. (1976) (9)
Inhibition of hexokinase by multisubstrate analogs. (1977) (9)
TELOMERASE REVERSE TRANSCRIPTASE EXPRESSION IS INCREASED EARLY IN BARRETTE’S METAPLASIA, DYSPLASIA, CARCINOMA SEQUENCE (2000) (9)
The prognostic role of Bcl-2 mRNA expression in curatively resected non-small cell lung cancer (NSCLC). (2010) (9)
Evidence that intracellular synthesis of 5-fluorouridine-5'-phosphate from 5-fluorouracil and 5-fluorouridine is compartmentalized. (1984) (8)
Rapid quantitative PCR for determination of relative gene expressions in tissue specimens. (1995) (8)
Ornithine decarboxylase mRNA expression in curatively resected non-small-cell lung cancer. (2010) (8)
Relative gene expression in normal and tumor tissue by quantitative RT-PCR. (2002) (8)
Rapid and sensitive molecular subtyping of microorganisms in clinical specimens (1993) (8)
Large-scale screening of ALK fusion oncogene transcripts in archival NSCLC tumor specimens using multiplexed RT-PCR assays. (2011) (8)
Prognostic value of the androgen receptor and its coactivators in patients with D1 prostate cancer. (2008) (8)
A longterm follow-up study of thymidylate synthase as a predictor for survival of patients with liver tumours receiving hepatic arterial infusion chemotherapy. (2004) (7)
Methotrexate analogues. 29. Effect of gamma-aminobutyric acid spacers between the pteroyl and glutamate moieties on enzyme binding and cell growth inhibition. (1986) (7)
Gene mutation status in circulating tumor DNA (ctDNA) and first-line FOLFOXIRI plus bevacizumab (bev) in metastatic colorectal cancer (mCRC) harboring RAS mutation. (2018) (7)
A molecular/epidemiologic analysis of expression of cyclooxygenases 1 and 2, use of nonsteroidal antiinflammatory drugs, and risk of colorectal adenoma. (2005) (7)
Gene expression of the mismatch repair gene MSH2 in primary colorectal cancer (2011) (7)
Deoxyribonucleoside-induced selective modulation of cytotoxicity and mutagenesis. (1985) (7)
Use of whole genome expression analysis of pancreatic adenocarcinoma to predict prognosis after OXi4503 surgery (2008) (7)
Detection of clonal T‐cell populations in gastrointestinal lymphomas by analysis of cRNA conformational polymorphisms of rearranged T‐cell‐receptor‐gamma genes (1994) (6)
Large-scale and small-scale methods for the preparation of 5,10-methylenetetrahydrofolate. (1982) (6)
Inhibition of phenylalanyl-tRNA synthetase by aromatic guanidines and amidines. (1975) (5)
Characterization of the mode of binding of substrates to the active site of Tetrahymena self-splicing RNA using 5-fluorouracil-substituted mini-exons. (1989) (5)
Immune checkpoint molecule expression measured using circulating cell-free RNA isolated from the blood of metastatic prostate cancer patients. (2018) (5)
Molecular detection and characterization of clonal cell populations in acute lymphocytic leukemia by analysis of conformational polymorphisms of cRNA molecules of rearranged T-cell-receptor-gamma and immunoglobulin heavy-chain genes. (1994) (5)
Quantitative determination of the ratio of mutated to normal ras genes in the blood of leukemia patients by allele-specific PCR. (1994) (5)
Theoretical considerations and in vitro concentration response studies with two human colorectal carcinoma cell lines. The rational experimental base for clinical studies in regional chemotherapy. (2000) (5)
Studies on the Mechanism of Fluoropyrimidine Cytotoxicity in L1210 Cells: Correlation with Inhibition of Thymidylate Synthetase but Not with Incorporation into RNA (1984) (5)
Evidence from chemical degradation studies for a covalent bond from 5-fluoro-2'-deoxyuridylate to N-5 of tetrahydrofolate in the ternary complex of thymidylate synthetase-5-fluoro-2'-deoxyuridylate-5,10-methylenetetrahydrofolate. (1985) (5)
Molecular markers associated with response and clinical outcome to cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer (BOND2) (2007) (4)
Markedly decreased binding of vincristine to tubulin in vinca alkaloid-resistant Chinese hamster cells is associated with selective overexpression of alpha and beta tubulin isoforms. (2000) (4)
Data-Driven Coherence Models (2010) (4)
P-752 Biomarkers for small cell lung cancer (SCLC): DNA methylationand GD2 synthase transcript levels (2005) (4)
Synthesis of 5-trifluoromethyl-2'-deoxyuridine 5'-phosphate and 5-trifluoromethyl-2'-deoxyuridine 5'-triphosphate. (1973) (4)
Multi-parametric liquid biopsy analysis of circulating tumor cells (CTCs), cell-free DNA (cfDNA), and cell-free RNA (cfRNA) in metastatic castrate resistant prostate cancer (mCRPC). (2018) (3)
Loss of heterozygosity at thymidylate synthase locus in Barrett's metaplasia, dysplasia, and carcinoma sequences (2009) (3)
Inhibition of Cyclin D 1 Expression in Human Pancreatic Cancer Cells Is Associated with Increased Chemosensitivity and Decreased Expression of Multiple Chemoresistance Genes 1 (1999) (3)
Biomarkers for cetuximab-based neoadjuvant radiochemotherapy in advanced rectal cancer. (2010) (3)
Quantitative determination of p16 gene expression by RT-PCR. (2004) (3)
Cyclooxygenase-2 (COX-2) mediated anti-apoptosis may occur via Bcl-2 in the progression of Barrett's esophagus to adenocarcinoma. (2004) (3)
Biochemical and molecular effects of UCN-01 in combination with 5-fluorodeoxyuridine in A431 human epidermoid cancer cells (2002) (3)
Gender differences in the predictive power of prognostic factors in NSCLC. (2004) (3)
Correlate with Levels of Thymidylate Synthase Colon Cancer As Compared with Hepatic Metastasis and Levels of E 2 F-1 Expression Are Higher in Lung Metastasis of Updated (2000) (2)
Different pancreatic cancer genomic risk prediction models derived from microdissected and non-microdissected paraffin-embedded tissue (2008) (2)
RETINOIC ACID RECEPTOR A(ALPHA) MESSENGER RNA EXPRESSION IS INCREASED AND RETINOIC ACID Y(GAMA)IS DECREASED IN BARRETTE'S INTESTINAL METAPLASIA, DYSPLASIA, ADENOCARCINOMA SEQUENCE (2001) (2)
P14.04 cfRNA from Liquid Biopsies Is More Abundant Than cfDNA, Informs Treatment Outcome and Is Concordant with Tissue (2021) (2)
FIELDS OF ABERREANT CPG ISLAND HYPERMETHYLATION IN BARRETTE’S ESOPHAGUS AND ASSOCIATED ADENOCARCINOMAS (2000) (2)
Measurements of total DNA and methylated tumor suppressor genes in the plasma of patients with metastatic non-small cell lung cancer (NSCLC) before, and after chemotherapy, as potential biomarkers for response to treatment (2005) (2)
The incorporation of trifluorothymidine into calf thymus DNA in a cell-free system does not lead to chain termination. (1980) (2)
Low HER 2/NEU gene expression is associated with pathological response to primary paclitaxel and radiation in locally advanced breast cancer (LABC) (2000) (2)
42 Original P53 status predicts for pathological response in locally advanced breast cancer treated pre-operatively with continuous infusion (C.I.) 5-fluorouracil (5FU) during radiotherapy (1996) (2)
Identification of mutations by RNA conformational polymorphism "bar code" analysis. (1995) (2)
P2.03b-039 Cell-Free (cf) DNA and cfRNA levels in Plasma of Lung Cancer Patients Indicate Disease Status and Predict Progression: Topic: Biomarkers (2017) (2)
Thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD), ERCC1, & thymidine phosphorylase gene expression in primary & metastatic (met) colorectal cancer (CRC) tissue in patients (pts) treated on a phase I trial of oxaliplatin (OX) & capecitabine (Xel) (2005) (2)
951 High Expression of Heparanase Is Significantly Associated with Dedifferentiation and Lymph Node Metastasis in Patients with Pancreatic Ductal Adenocarcinomas and Correlated to PDGFA and Via HIF1a to HB-EGF and bFGF (2008) (2)
Abstract 2693: MDR1 and ERCC1 expression predict outcome in patients with locally advanced bladder cancer and adjuvant chemotherapy (2010) (2)
PD2.01 PD-L1 and Other Potential Predictive Biomarkers Measured in Plasma by RT-PCR in cfRNA and cfDNA to Monitor Clinical Responses in Metastatic Lung Cancer Patients (2019) (2)
Molecular Markers of Chemotherapy Resistance in Colorectal Cancer (2002) (2)
Correlation of multidrug-resistance gene (MDR1) expression levels and outcome to adjuvant cisplatin/MTX based chemotherapy in patients enrolled in the AUO-AB 05/95 phase III trial. (2009) (1)
DNA of Patients with Lung Cancer Methylation Analysis in Tumor Tissue , Serum , and Plasma Quantitative Adenomatous Polyposis Coli Promoter Updated (2002) (1)
INTERACTION OF 5-ETHYNYL-2′-DEOXYURIDYLATE WITH THYMIDYLATE SYNTHETASE (1982) (1)
SYNTHESIS AND BIOLOGICAL ACTIVITY OF 5-FLUORO-2′,3′-DIDEOXY-3′-FLUOROURIDINE AND ITS 5′-PHOSPHATE (1984) (1)
The Significance of Concentration and Exposure Time in the Clinical Use of Fluorinated Pyrimidines (1988) (1)
Dynamic changes in RAS gene status in circulating tumour DNA: a phase II trial of first-line FOLFOXIRI plus bevacizumab for RAS-mutant metastatic colorectal cancer (JACCRO CC-11) (2022) (1)
Gene expression differences in cell-free RNA between prostate cancer patients and healthy individuals. (2018) (1)
Biochemical Loci for Modulation of 5-Fluorouracil Activity (1986) (1)
Regulation of MLH1 mRNA and protein expression by promoter methylation in primary colorectal cancer: a descriptive and prognostic cancer marker study (2013) (1)
Use of cell-free circulating RNA (cfRNA) levels in plasma and expression of HER2 and PD-L1 to monitor disease status in metastatic cancer patients. (2018) (1)
Synthesis and Biological Studies of 3-(β-D-Ribofuranosyl)-2,3-dihydro-6H-1,3-oxazine-2,6-dione, a New Pyrimidine Nucleoside Analog Related to Uridine. (1976) (1)
Correlation of cell-free circulating DNA, RNA, and PD-L1 from plasma with clinical response in patients with metastatic lung and breast cancers. (2017) (1)
BRCA1 mRNA expression patterns in a large lung cancer cohort. (2011) (1)
Gene expression of MLH1 related to microsatellite instability, immuno-histochemistry, and promoter hypermethylation in colorectal cancer. (2006) (1)
Measurements of total DNA and methylated tumor suppressor genes in the plasma of patients with small cell lung cancer (SCLC) (2005) (1)
Clinical verification of circulating tumor RNA (ctRNA) as novel pretreatment predictor and tool for quantitative monitoring of treatment response in metastatic colorectal cancer (mCRC): A biomarker study of the DEEPER trial. (2019) (1)
5-fluorouracil related gene expression levels in primary colorectal cancer and corresponding liver metastases (2005) (1)
Upregulation of ornithine decarboxylase MRNA expression in Barrett's esophagus (2000) (1)
997 Sonic Hedgehog Gene Expression in Barrett's Esophagus and Esophageal Adenocarcinoma (2008) (1)
[Molecular markers as basis for chemotherapy?]. (2000) (1)
RNA-based biomarker signatures in plasma as an independent predictor of outcome to chemotherapy in lung, colon, and breast cancers: Correlation of relative PD-L1 expression with immunotherapy outcomes. (2019) (1)
The relationship between epidermal growth factor receptor (EGFR) mRNA levels and protein expression in primary colorectal cancer and corresponding liver metastases (2008) (1)
Plasma DNA: A Molecular Marker of Surgical Insult and Postoperative Recovery in Esophageal Cancer (2008) (1)
An update of pharmacogenetic analysis of adjuvant rectal cancer patients treated with 5-fluorouracil and pelvic radiation in a phase III intergroup trial (INT-0144, SWOG 9304) (2008) (0)
The role of retinoid X receptor mRNA expression in Barrett's esophagus and Barrett's associated adenocarcinoma of the esophagus (2003) (0)
Epidermal growth factor receptor (EGFR) mRNA expression levels are strongly correlated between primary colorectal cancer and corresponding liver metastases (2007) (0)
Molecular determinants of capecitabine efficacy in colorectal cancer. (2006) (0)
Summation of Session II (1988) (0)
SYNTHESIS AND BIOLOGICAL ACTIVITY OF 5-FLUORO-2′-DEOXYURIDINE 5′-PHOSPHORODIAMIDATES (1981) (0)
Abstract P2-02-16: Use of cell-free circulating RNA and expression of PD-L1 and HER2 in plasma to monitor and predict clinical response in metastatic breast cancer patients (2018) (0)
Molecular signature of esophageal adenocarcinoma derived from microarray analysis of paraffin-embedded specimens predicts systemic recurrence following resection (2007) (0)
Thymidylate synthase quantitation of chemosensitivity testing predicts response and survival of patients with liver tumours receiving arterial infusion chemotherapy (1999) (0)
Derivation of genomic risk models for early relapse in colorectal cancer from microdissected FFPE tumor and from mucosal tissue (2008) (0)
tor Regulation after Transfection into a Cell Line Deficient in the cAMP-Dependent (1989) (0)
Normal Liver of Patients Given Intravenous 5-Fluorouracil Thymidylate Synthetase Inhibition in Malignant Tumors and Updated (2006) (0)
Modulates DT-Diaphorase Activity and Mitomycin Sensitivity Colon Carcinoma Cells : Characterization of a Mutation Which NAD ( P ) H : Quinone Oxidoreductase Gene Expression in Human Updated (2006) (0)
233 Thymidylate synthase is a predictor for response and survival of patients with isolated unresectable liver tumors receiving hepatic artery infusion chemotherapy (2003) (0)
Molecular signatures generated with RNA isolated from formalin-fixed paraffin-embedded tumor specimens differentiate metastatic and non-metastatic primary colorectal cancer. (2016) (0)
2008 Non-Invasive testing of gene expressions using cell-free RNA increases the chemotherapy target information generated from cell-free DNA testing (2015) (0)
Interim results of two prospective trials measuring plasma total DNA and methylated genes before and after surgery, or chemotherapy, in patients with non-small cell lung cancer (NSCLC). (2006) (0)
Molecular signatures generated with RNA Isolated from formalin-fixed paraffin-embedded tumor specimens differentiate metastatic and non-metastatic primary breast cancer. (2006) (0)
P2.01-056 Use of Cell-Free Circulating RNA (cfRNA) Expression of PD-L1 and ERCC1 in Plasma to Monitor Response to Therapy in NSCLC (2017) (0)
Evaluation of 5-FU metabolism-relating enzyme gene expression levels using quantitative real-time RT-PCR from formalin fixed parafine embedded samples. (2006) (0)
Association of intratumoral gene expression levels of thymidine phosphorylase (TP) and VEGF with clinical outcome in stage II/III rectal cancer patients treated with 5-fluorouracil and pelvic radiation in a phase III intergroup trial (SWOG 9304). (2010) (0)
Thymidylate synthase polymorphisms and its mRNA expression levels as independent chemo-predictive markers in esophageal adenocarcinoma patients receiving 5-fluorouracil chemotherapy. (2006) (0)
Prospective study of tumor suppressor gene (TSG) methylation as a prognostic biomarker in surgically resected non-small cell lung cancer (NSCLC). (2012) (0)
Messenger RNA expression of TS and ERCC1 in primary colorectal cancer and corresponding liver metastasis. (2006) (0)
Methotrexate Analogues. Part 29. Effect of γ-Aminobutyric Acid Spacers between the Pteroyl and Glutamate Moieties of Enzyme Binding and Cell Growth Inhibition. (1987) (0)
Predictive Biomarkers and Personalized Medicine Biomarkers for Cetuximab-Based Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer (2011) (0)
Thymidylate synthase polymorphism in the development of Barrett's associated adenocarcinoma. (2004) (0)
The effects of thymidine (tdr) on the cytotoxicity of n-methyl-n'- -nitro-n-nitrosoguanidine (mnng) in chinese hamster cells and in mouse leukemia cells. Abstr. (1981) (0)
MA19.06 Blood Based Biomarkers: RNA, KRAS and PD-L1 Strongly Matching with Tissue and Showing Correlation with Clinical Responses In NSCLC Patient’s (2018) (0)
VEGF receptor 1 and heparanase expression as prognostic factors in cholangiocellular carcinoma. (2011) (0)
Identification and Characterization of Monoclonal Lymphoid Populations by Analysis of Complementary RNA of Clonespecific DNA Sequences (1994) (0)
Pretreatment COX-2 protein expression is a predictor of tumor regression in rectal cancer treated with preoperative short-term chemoradiotherapy. (2006) (0)
M1974 Cdx-2 and Sonic Hedgehog Gene Expression in the Proximal, Middle, and Distal Regions of Columnar Mucosa in Long Segment Barrett's Esophagus (2008) (0)
INHIBITION OF PHENYLALANYL-TRNA SYNTHETASE BY AROMATIC GUANIDINES AND AMIDINES (1975) (0)
A lung cancer genomic risk prediction model derived from paraffin-embedded tissue. (2006) (0)
Microarray analysis of formalin-fixed paraffin-embedded specimens shows distinct gene expression patterns in tumors containing the transforming growth factor beta receptor 6A polymorphism (TGFBR1*6A) (2016) (0)
Plasma DNA: A molecular marker for the pattern of dissemination of esophageal cancer (2007) (0)
Synthesis and Biological Activity of 5′-Substituted S-Fluoropyrimidine Nucleosides. (1983) (0)
Primary paclitaxel in breast cancer: Is beta-tubulin a predictor for pathological response? (1998) (0)
A process for the isolation of RNA from formalin-fixed, paraffin-embedded tissue samples (2000) (0)
Biochemical and antineoplastic effects of 5-fluoro-2'-deoxy- uridine-5'-phosphordiamidates. Abstr. (1980) (0)
Exploration of the active site of mammalian thymidylate synthetase. Abstr. (1972) (0)
Gene and protein expression profile and prognosis in high-risk primary breast cancer. (2004) (0)
Intratumoral COX-2 gene expression is a predictive factor for colorectal cancer response to chemotherapy with S-1 as well as a prognostic factor for survival of patients after S-1 chemotherapy. (2004) (0)
Enhancement of therapeutic response to fluorinated pyrimidines by coadminstration of inhibitors of deoxyuridylate (dump) synthesis. Abstr. (1978) (0)
Differential canonical pathways derived from microarrays using RNA from paraffin-embedded non-small cell lung cancer tissue. (2016) (0)
Association of TS and ERCC1 mRNA expressions with overall survival in patients enrolled in CONFIRM 1 and 2. (2010) (0)
Glutathione S-transferase P1 mRNA expression is down-regulated in patients with Barrett's esophagus and esophageal adenocarcinoma (2001) (0)
ERCC1 expression as a predictor for chemosensitivity in recurrent colorectal cancer patients receiving cisplatinum (CDDP) plus S-1 chemotherapy. (2006) (0)
Correlation between thymidylate synthase (TS) genotype, clinical outcome, and TS mRNA expression in subjects treated with oxaliplatin (OX) and capecitabine (Cape). (2006) (0)
[Expression of p16 and p16 beta in squamous epithelial carcinomas and adenocarcinomas of the esophagus: differences in regulation dependent on kind of tumor and histology]. (1998) (0)
Use of ERCC1 gene expression to predict the effectiveness of platin-based therapy in colorectal, ovarian and lung cancer (2008) (0)
Upregulation of c-myb mRNA expression in barrett's esophagus (2000) (0)
Epidermal Growth Factor Receptor Messenger RNAExpression , Gene Dosage , and Gefitinib Sensitivity in Non ^ Small Cell Lung Cancer (2006) (0)
Inhibition of Dihydrofolate Reductase and Thymidylate Synthase by Methotrexate Polyglutamate Analogues Lacking "Internal" α-Carboxyl Groups (1986) (0)
Anti-apoptosis and pro-apoptosis gene expressions in Barrett's epithelial tumorigenesis (2005) (0)
Purification of thymidylate synthetase with 2'-deoxyuridylate-agarose. (1974) (0)
Response prediction in hepatic artery infusion with fluoropyrimidines using cell culture and thymidylate synthase quantitation (1995) (0)
Predictive value of preoperative plasma DNA level for early recurrence after resection in esophageal adenocarcinoma (2008) (0)
Gene expressions of VEGF and Survivin as molecular markers of lymph node involvement in patients with locally advanced rectal cancer. (2004) (0)
Abstract P2-09-17: Limited Gene Expression Profiling as Predictor of Response to Neoadjuvant Chemotherapy (NCT) with Docetaxel, Doxorubicin, Cyclophosphamide (TAC), or AC and Nab-Paclitaxel and Carboplatin +/− Trastuzumab in Patients (pts) with Locally Advanced (LABC) Stage II-III and Inflammatory B (2010) (0)
Cancer chemotherapy with 5'-phosphordiamidates of 5-fluoro-2'- -deoxyuridine. Abstr. (1977) (0)
The Gene Expression Profile of Cardiac Intestinal Metaplasia Is Similar to Barrettʼs Esophagus, Not Gastric Intestinal Metaplasia: 60 (2005) (0)
NAD ( P ) H : Quinone Oxidoreductase Gene Expression in Human Colon Carcinoma Cells : Characterization of a Mutation Which Modulates DT-Diaphorase Activity and Mitomycin Sensitivity 1 (2006) (0)
P59. Towards the molecular characterization of disease: Comparison of molecular and histological analysis of esophageal epithelia (2006) (0)
I point mutations in human ition polymorphism ! (2005) (0)
P1.01-68 Monitoring Clinical Responses Measuring PD-L1 in cfRNA in Plasma of Non-Small Cell Lung Cancer Patients Undergoing Systemic Therapy (2019) (0)
SYNTHESIS OF 5-TRIFLUOROMETHYL-2′-DEOXYURIDINE 5′-PHOSPHATE AND 5-TRIFLUOROMETHYL-2′-DEOXYURIDINE 5′-TRIPHOSPHATE (1973) (0)
Heparanase and Survivin--potential markers of aggressiveness of colon cancers (2007) (0)
Process for the isolation of RNA from fixed tissue specimens with formalin and embedded in paraffin. (2000) (0)
Gene and protein expression profile and prognosis in high-risk primary breast cancer (2004) (0)
New Biomarkers to Follow Therapy Response in Plasma of NSCLC Patients: PS5 (2018) (0)
Recent Studies on the Interaction of 5-Fluoro-2′-deoxyuridylate with Thymidylate Synthetase (1979) (0)
Use of molecular signatures of gastric cancers derived from microarray analysis of paraffin-embedded specimens to predict the degree of response to CPT11/S-1 chemotherapy (2008) (0)
招待講演2Molecular analysis of endoscopic biopsies from gastrointestinal cancers (1997) (0)
Antitumor activity of 5'-deoxy-5'-substituted-5-fluorouri- dine derivatives. Abstr. (1982) (0)
Epidermal growth factor receptor mRNA expression level predicts for survival in metastatic colorectal tumors (2001) (0)
Thymidylate synthase polymorphism in the development of Barrett's associated adenocarcinoma (2004) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Peter. V. Danenberg?

Peter. V. Danenberg is affiliated with the following schools: